Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second-line lenalidomide + dexamethasone induction in multiple myeloma.

Cancer Med · 2018 · PMC6010717 · PMID 29673108

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

an apparent trendno p-value reported

did not reach statistical significanceno p-value reported

Although there was an apparent trend toward increased TTP in the Len+Dex arm, this did not reach statistical significance.

also in 709 other papers

a clear trendno p-value reported

There was a clear trend toward increased depth of response and PFS with Len‐Dex over Len.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.